Selective inhibitor of monoacylglycerol hydrolysis; blocks 2-oleoyl glycerol hydrolysis in the cytosolic (IC50 = 4.5 µM) and membrane (IC50 = 19 µM) fractions of rat cerebella.

A potent activator of Nrf2-regulated activity, both in vitro (10 μM) and in mice (50 mg/kg).

An analog of AEA with no intrinsic binding affinity for either CB1 or CB2 receptors; potently inhibits AEA reuptake in U937 lymphoma cells (IC₅₀ = 3 µM); may enhance endocannabinoid signalling by augmenting endocannabinoid concentrations.

An analog of AEA that exhibits weak or no binding to the human CB1 receptor (Ki >1 µM); inhibits rat glial gap junction cell-cell communication at a concentration of 50 µM.

An analog of AEA that binds to the human CB1 receptor with a Ki value of 60 nM; inhibits rat glial gap junction cell-cell communication at a concentration of 50 µM.